Form 4: BillionToOne CEO Executes Stock Options and Sales

CEO Oguzhan Atay exercised stock options and sold shares of BillionToOne, Inc. under a pre-established Rule 10b5-1 trading plan.

Summary

• Reporting person Oguzhan Atay, Chairman and CEO, exercised options for 26,250 shares of Class A Common Stock at an exercise price of $2.80.
• A total of 26,250 shares were sold in multiple transactions on June 8, 2026, at prices ranging from $94.76 to $100.87 per share.
• The reporting person also converted 10,000 shares of Class B Common Stock into Class A Common Stock, which were subsequently gifted on June 9, 2026.
• Additional sales of 12,500 shares held by the reporting person's spouse were executed at prices between $96.45 and $100.00 per share.
• All transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on March 6, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; insider selling is expected behavior for executives and the use of a 10b5-1 plan mitigates concerns regarding market timing.

Positives

• The CEO maintains a significant remaining equity stake in the company following the transactions.
• Transactions were executed under a pre-planned Rule 10b5-1 program, indicating a systematic approach to liquidity rather than reactive selling.
• The exercise of options at $2.80 demonstrates long-term value creation given the current market price.

Negatives

• The filing reflects a reduction in direct and indirect beneficial ownership by the CEO and his spouse.

Risks

• Future sales by insiders under Rule 10b5-1 plans may continue to impact the supply of shares in the market.
• Concentration of ownership remains subject to the conversion terms of Class B shares.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing, as it is limited to insider transaction reporting.

Management Comments

• The reporting person confirms that the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on March 6, 2026.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives to diversify personal holdings and is generally viewed as neutral by the market when pre-planned.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is consistent with best practices for corporate governance among U.S. publicly traded companies to avoid allegations of insider trading.
• The scale of the sale relative to the CEO's total holdings is typical for executive liquidity events in high-growth biotech/tech firms.

Related Party Transactions

• The filing discloses transactions involving shares held by the spouse of the reporting person.

Stakeholder Impact

• Shareholders should note the reduction in insider ownership, though the systematic nature of the sales suggests no change in long-term strategic outlook.

Next Steps

• Continued monitoring of future Form 4 filings for additional transactions under the established 10b5-1 plan.

Key Dates

Keywords

BillionToOne, BLLN, Insider Trading, Form 4, Rule 10b5-1, Equity Compensation